$20.75
0.281.34%
Last update: Nov 3, 10:56 AM
Acadia Pharmaceuticals Inc (ACAD) Stock Price, Quote, News & History
ACADNASDAQ
Analysts cut targets for GWW, IE and COST, while raising targets for OKTA, AXGN, ZS and DRI; ratings remained unchanged.
You can purchase shares of Acadia Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.
Other companies in Acadia Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Acadia Pharmaceuticals has a consensus price target of $29.86.
The stock price for Acadia Pharmaceuticals (NASDAQ: ACAD) is $20.745 last updated November 3, 2026 at 10:56 AM EST.
There are no upcoming dividends for Acadia Pharmaceuticals.
Acadia Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acadia Pharmaceuticals.
Acadia Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare...
